Boehringer Ingelheim wins Frost & Sullivan Award
7 September 2011 | By Boehringer Ingelheim
Boehringer Ingelheim wins the '2011 European Bio Pharmaceutical Contract Manufacturing Competitive Strategy Leadership Award'...
List view / Grid view
7 September 2011 | By Boehringer Ingelheim
Boehringer Ingelheim wins the '2011 European Bio Pharmaceutical Contract Manufacturing Competitive Strategy Leadership Award'...
6 September 2011 | By Biogen Idec
Biogen Idec will acquire 100% of Dompé shares in its joint ventures in both Italy and Switzerland...
6 September 2011 | By Bayer
Study to be reviewed by the FDA Cardiovascular and Renal Drugs Advisory Committee...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced that Dr. Alexander Makarov, its director of global research for life sciences mass spectrometry, has received the first HUPO Science and Technology Award from the Human Proteome Organization (HUPO).
6 September 2011 | By Pfizer
Pfizer and Icagen announced the successful completion of the initial cash tender offer...
6 September 2011 | By GSK
GSK & the BARDA have agreed to a contract that will support the development by GSK of a potentially new antibiotic against both hospital Gram negative & biothreat pathogens...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced at the Human Proteome Organization (HUPO) 2011 World Congress the establishment of a new Biomarker Translational Center (BT Center).
6 September 2011 | By Evotec AG
Evotec's MAO-B inhibitor in patients with Alzheimer's disease (AD) to be developed...
5 September 2011 | By Novartis
The European Commission has approved Afinitor® (everolimus) tablets...
5 September 2011 | By Astellas Pharma Inc.
Astellas will obtain worldwide exclusive rights...
5 September 2011 | By Pfizer
Expiration date of its tender offer for all outstanding shares of common stock of Icagen has been extended...
5 September 2011 | By Gilead Sciences, Inc.
Change does not affect ongoing "All Oral" clinical trials evaluating multiple direct-acting antivirals in combination...
2 September 2011 | By The Scott Partnership
Free application note available to download...
2 September 2011 | By AstraZeneca
SATURN measures the impact of rosuvastatin and atorvastatin on the progression of atherosclerosis in high risk patients...
2 September 2011 | By Pfizer
Facility to house cardiovascular, metabolic and endocrine disease and neuroscience research units...